Comparative prognostic performance of staging systems for hepatocellular carcinoma: Evidence from a Vietnamese cohort study

Figure 5 Receiver operating characteristic curves showing the discriminatory ability of staging and scoring systems in predicting 1-year and 3-year mortality across hepatitis B virus, hepatitis C virus, and non-B-non-C subgroups. A and B: Hepatitis B virus subgroup 1-year mortality (A) and 3-year mortality (B); C and D: Hepatitis C virus subgroup 1-year mortality (C) and 3-year mortality (D); E and F: Non-B-non-C subgroup 1-year mortality (E) and 3-year mortality (F). BCLC: Barcelona Clinic Liver cancer; HKLC: Hong Kong Liver Cancer; CLIP: Cancer of the Liver Italian Program; ITA.LI.CA: Italian Liver Cancer; JIS: Japan Integrated staging; MESIAH: Model to estimate survival in ambulatory hepatocellular carcinoma patients; AUC: Area under the curve; ROC: Receiver operating characteristic.